BCL2L2 antibody
Quick Overview for BCL2L2 antibody (ABIN6654583)
Target
See all BCL2L2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- Purified
-
Purity
- Protein G affinity chromatography
-
Immunogen
- Full-length recombinant human protein was used as the immunogen for this Bcl2L2 antibody.
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Bcl2L2 antibody to be titered up or down for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1) -
Restrictions
- For Research Use only
-
-
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the Bcl2L2 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- BCL2L2 (BCL2-Like 2 (BCL2L2))
-
Alternative Name
- Bcl2L2 / Bcl-W
-
Background
- Bcl2L2, also called BCLW, promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
Target
-